Imidapril Hydrochloride

盐酸咪唑普利

Report date: 2025/12/24 20:00:51
NME

Base Information

Drug NameImidapril Hydrochloride
Drug Alias Name盐酸咪达普利咪达普利NovarokTanatrilTA-6366 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsEssential HypertensionHypertensionHypertension, Renal +[4] 
Global Approved IndicationsEssential HypertensionHypertensionHypertension, Renal
Approved Indications in ChinaEssential HypertensionHypertension, Renal
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryItalyEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUniversity Of Pavia
China Registration ClassN/A

Develop Information

Active CompaniesTanabe Europe NvMitsubishi Tanabe PharmaGrand Pharma (Tianjin) Co Ltd
Inactive CompaniesUniversity Of Pavia
Active IndicationsEssential HypertensionHypertensionHypertension, Renal +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeC09AA16
Related LinksWikipediaKEGG